miR-146a promotes the initiation and progression of melanoma by activating Notch signaling

Oncogenic mutations in BRAF and NRAS occur in 70% of melanomas. In this study, we identify a microRNA, miR-146a, that is highly upregulated by oncogenic BRAF and NRAS. Expression of miR-146a increases the ability of human melanoma cells to proliferate in culture and form tumors in mice, whereas knockdown of miR-146a has the opposite effects. We show these oncogenic activities are due to miR-146a targeting the NUMB mRNA, a repressor of Notch signaling. Previous studies have shown that pre-miR-146a contains a single nucleotide polymorphism (C>G rs2910164). We find that the ability of pre-miR-146a/G to activate Notch signaling and promote oncogenesis is substantially higher than that of pre-miR-146a/C. Analysis of melanoma cell lines and matched patient samples indicates that during melanoma progression pre-miR-146a/G is enriched relative to pre-miR-146a/C, resulting from a C-to-G somatic mutation in pre-miR-146a/C. Collectively, our results reveal a central role for miR-146a in the initiation and progression of melanoma. DOI: http://dx.doi.org/10.7554/eLife.01460.001

[1]  Y Taya,et al.  Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. , 2000, Genes & development.

[2]  J. Woo,et al.  A single nucleotide polymorphism in microRNA‐146a is associated with the risk for nasopharyngeal carcinoma , 2013, Molecular carcinogenesis.

[3]  Katharina J Hoff,et al.  The effect of sequencing errors on metagenomic gene prediction , 2009, BMC Genomics.

[4]  L. Chin,et al.  Malignant melanoma: genetics and therapeutics in the genomic era. , 2006, Genes & development.

[5]  Robert A. Weinberg,et al.  Ras oncogenes: split personalities , 2008, Nature Reviews Molecular Cell Biology.

[6]  Hui-Kuan Lin,et al.  Activation of Ras/PI3K/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells. , 2012, Cancer research.

[7]  Barbara Jarzab,et al.  Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma , 2008, Proceedings of the National Academy of Sciences.

[8]  J.,et al.  The New England Journal of Medicine , 2012 .

[9]  L. Chin,et al.  Melanoma: from mutations to medicine. , 2012, Genes & development.

[10]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[11]  K. G. Guruharsha,et al.  The Notch signalling system: recent insights into the complexity of a conserved pathway , 2012, Nature Reviews Genetics.

[12]  Pu Li,et al.  Genetic variants in miRNAs predict bladder cancer risk and recurrence. , 2012, Cancer research.

[13]  D. Morrison,et al.  MAP kinase pathways. , 2012, Cold Spring Harbor perspectives in biology.

[14]  I. Behrmann,et al.  Signatures of microRNAs and selected microRNA target genes in human melanoma. , 2010, Cancer research.

[15]  Michael R Green,et al.  HIV-1 Tat Stimulates Transcription Complex Assembly through Recruitment of TBP in the Absence of TAFs , 2005, PLoS biology.

[16]  D. Schadendorf,et al.  Somatic alterations in the melanoma genome: A high‐resolution array‐based comparative genomic hybridization study , 2010, Genes, chromosomes & cancer.

[17]  Richard Marais,et al.  The RAF proteins take centre stage , 2004, Nature Reviews Molecular Cell Biology.

[18]  Matthew E Ritchie,et al.  Using the R Package crlmm for Genotyping and Copy Number Estimation. , 2011, Journal of statistical software.

[19]  T. Golde,et al.  Rational targeting of Notch signaling in cancer , 2008, Oncogene.

[20]  P. Sharp,et al.  Function and localization of microRNAs in mammalian cells. , 2006, Cold Spring Harbor symposia on quantitative biology.

[21]  Y. Jan,et al.  Control of Daughter Cell Fates during Asymmetric Division: Interaction of Numb and Notch , 1996, Neuron.

[22]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.

[23]  I. Umelo,et al.  miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells , 2013, PloS one.

[24]  C. Croce Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.

[25]  J. Handa,et al.  Notch Signaling Promotes Growth and Invasion in Uveal Melanoma , 2012, Clinical Cancer Research.

[26]  A. Capobianco,et al.  Notch signalling in solid tumours: a little bit of everything but not all the time , 2011, Nature Reviews Cancer.

[27]  S. Nishikawa,et al.  Notch signaling via Hes1 transcription factor maintains survival of melanoblasts and melanocyte stem cells , 2006, The Journal of cell biology.

[28]  M. Herlyn,et al.  Normal human melanocyte homeostasis as a paradigm for understanding melanoma. , 2005, The journal of investigative dermatology. Symposium proceedings.

[29]  Xavier Messeguer,et al.  PROMO: detection of known transcription regulatory elements using species-tailored searches , 2002, Bioinform..

[30]  L. Larue,et al.  Melanoblasts' proper location and timed differentiation depend on Notch/RBP-J signaling in postnatal hair follicles. , 2008, The Journal of investigative dermatology.

[31]  C. Croce,et al.  MicroRNAs in Cancer. , 2009, Annual review of medicine.

[32]  A. Leonardi,et al.  Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a. , 2010, The Journal of clinical endocrinology and metabolism.

[33]  G. Sava,et al.  Inhibition of the MEK/ERK signaling pathway by the novel antimetastatic agent NAMI-A down regulates c-myc gene expression and endothelial cell proliferation. , 2002, European journal of biochemistry.

[34]  P. Linsley,et al.  miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice , 2011, The Journal of experimental medicine.

[35]  S. Ogawa,et al.  Both Notch1 and Notch2 contribute to the regulation of melanocyte homeostasis , 2007, Pigment cell & melanoma research.

[36]  V. Ambros,et al.  MicroRNAs and Other Tiny Endogenous RNAs in C. elegans , 2003, Current Biology.

[37]  J. Nevins,et al.  Ras enhances Myc protein stability. , 1999, Molecular cell.

[38]  R. Lidereau,et al.  Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers , 2011, EMBO molecular medicine.

[39]  K. Flaherty,et al.  Inhibition of mutated, activated BRAF in metastatic melanoma. , 2010, The New England journal of medicine.

[40]  Kam Y. J. Zhang,et al.  Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma , 2010, Nature.

[41]  Jun S. Song,et al.  Lineage-Specific Transcriptional Regulation of DICER by MITF in Melanocytes , 2010, Cell.

[42]  C. Ciccarelli,et al.  Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors , 2006, Molecular Cancer.

[43]  E. Furth,et al.  The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors. , 2010, Cancer research.

[44]  P. Khavari,et al.  Use of human tissue to assess the oncogenic activity of melanoma-associated mutations , 2005, Nature Genetics.

[45]  Jean-Philippe Brunet,et al.  The melanocyte differentiation program predisposes to metastasis after neoplastic transformation , 2005, Nature Genetics.

[46]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature reviews genetics.

[47]  P. Pollock,et al.  Active Notch1 confers a transformed phenotype to primary human melanocytes. , 2009, Cancer research.

[48]  M. Herlyn,et al.  Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression. , 2005, The Journal of clinical investigation.

[49]  Y. Duan,et al.  Cyclic stretch induced miR-146a upregulation delays C2C12 myogenic differentiation through inhibition of Numb. , 2009, Biochemical and biophysical research communications.

[50]  R. Vyzula,et al.  Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer. , 2012, World journal of gastroenterology.

[51]  Chelsea C Pinnix,et al.  Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression. , 2006, Cancer research.

[52]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[53]  H. Rui,et al.  ErbB2 Induces Notch1 Activity and Function in Breast Cancer Cells , 2008, Clinical and translational science.

[54]  The rs2910164 G>C polymorphism in microRNA-146a is associated with the incidence of malignant melanoma , 2013, Melanoma research.

[55]  Doron Betel,et al.  Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. , 2009, Genes & development.

[56]  Shu-Chun Lin,et al.  Association between the rs2910164 polymorphism in pre-mir-146a and oral carcinoma progression. , 2012, Oral oncology.

[57]  J. Downward Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.

[58]  N. Hayward,et al.  MicroRNA regulation of melanoma progression , 2012, Melanoma research.

[59]  Tsung-Cheng Chang,et al.  Widespread microRNA repression by Myc contributes to tumorigenesis , 2008, Nature Genetics.